0001752724-22-072236.txt : 20220325 0001752724-22-072236.hdr.sgml : 20220325 20220325122224 ACCESSION NUMBER: 0001752724-22-072236 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220325 PERIOD START: 20221031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price International Funds, Inc. CENTRAL INDEX KEY: 0000313212 IRS NUMBER: 521175211 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02958 FILM NUMBER: 22769488 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL TRUST DATE OF NAME CHANGE: 19900301 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUND INC DATE OF NAME CHANGE: 19890914 0000313212 S000001492 T. Rowe Price European Stock Fund C000004011 T. Rowe Price European Stock Fund PRESX C000184317 T. Rowe Price European Stock Fund-I Class TEUIX C000225808 T. Rowe Price European Stock Fund-Z Class TRZPX NPORT-P 1 primary_doc.xml NPORT-P false 0000313212 XXXXXXXX S000001492 C000225808 C000004011 C000184317 T. ROWE PRICE INTERNATIONAL FUNDS, INC. 811-02958 0000313212 549300O4BT3AMY6OUC26 100 East Pratt Street Baltimore 21202 410-345-2000 T. Rowe Price European Stock Fund S000001492 F02UHRPTUVEKSDNQDB53 2022-10-31 2022-01-31 N 1239013297.00 6981412.89 1232031884.11 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 4491.43000000 N Alcon Inc 549300LDT5AP8S0NBM78 Alcon Inc 000000000 258922.00000000 NS 19965119.95000000 1.620503511921 Long EC CORP CH N 2 N N N Experian PLC 635400RXXHHYT1JTSZ26 Experian PLC 000000000 395378.00000000 NS 16514109.32000000 1.340396261897 Long EC CORP IE N 2 N N N Sanofi 549300E9PC51EN656011 Sanofi 000000000 253499.00000000 NS 26506372.77000000 2.151435617199 Long EC CORP FR N 2 N N N Mayr Melnhof Karton AG 5299001AMHDLKUM80611 Mayr Melnhof Karton AG 000000000 44633.00000000 NS 8683486.85000000 0.704810237624 Long EC CORP AT N 2 N N N Greggs PLC 213800I71QMUFJ64IW20 Greggs PLC 000000000 308663.00000000 NS 11194372.62000000 0.908610626427 Long EC CORP GB N 2 N N N Cellnex Telecom SA 5493008T4YG3AQUI7P67 Cellnex Telecom SA 000000000 444016.00000000 NS 20134178.26000000 1.634225422221 Long EC CORP ES N 2 N N N Trainline PLC 213800HO26VXTFJ4MO71 Trainline PLC 000000000 1616448.00000000 NS 4893707.21000000 0.397206214637 Long EC CORP GB N 2 N N N BAWAG Group AG 529900S9YO2JHTIIDG38 BAWAG Group AG 000000000 290308.00000000 NS 17422878.12000000 1.414158054244 Long EC CORP AT N 2 N N N Akzo Nobel NV 724500XYIJUGXAA5QD70 Akzo Nobel NV 000000000 198735.00000000 NS 20570593.41000000 1.669647813121 Long EC CORP NL N 2 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML Holding NV 000000000 72613.00000000 NS 49180373.69000000 3.991810140979 Long EC CORP NL N 2 N N N FinecoBank Banca Fineco SpA 549300L7YCATGO57ZE10 FinecoBank Banca Fineco SpA 000000000 753360.00000000 NS 12665684.39000000 1.028032192458 Long EC CORP IT N 2 N N N Barry Callebaut AG 213800Y5RWKLDPUTT265 Barry Callebaut AG 000000000 6699.00000000 NS 15378414.95000000 1.248215662950 Long EC CORP CH N 2 N N N Bridgepoint Group PLC 213800KFNMVI8PDZX472 Bridgepoint Group PLC 000000000 1259146.00000000 NS 6553776.32000000 0.531948596828 Long EC CORP GB N 2 N N N Partners Group Holding AG 549300I3IVVWZWDHI788 Partners Group Holding AG 000000000 8616.00000000 NS 12012417.50000000 0.975008654802 Long EC CORP CH N 2 N N N Edenred 9695006LOD5B2D7Y0N70 Edenred 000000000 405940.00000000 NS 17436087.13000000 1.415230186400 Long EC CORP FR N 2 N N N Symrise AG 529900D82I6R9601CF26 Symrise AG 000000000 140476.00000000 NS 16786797.23000000 1.362529448020 Long EC CORP DE N 2 N N N Dechra Pharmaceuticals PLC 213800J4UVB5OWG8VX82 Dechra Pharmaceuticals PLC 000000000 222975.00000000 NS 12524296.87000000 1.016556229715 Long EC CORP GB N 2 N N N InterContinental Hotels Group 2138007ZFQYRUSLU3J98 InterContinental Hotels Group PLC 000000000 278056.00000000 NS 18372122.09000000 1.491205083809 Long EC CORP GB N 2 N N N Valmet Oyj 213800D9O7FUQDH83V62 Valmet Oyj 000000000 348781.00000000 NS 13321459.62000000 1.081259323870 Long EC CORP FI N 2 N N N ROCKWOOL International A/S 213800QRC7LNX935OZ09 ROCKWOOL International A/S 000000000 43088.00000000 NS 16503149.96000000 1.339506726477 Long EC CORP DK N 2 N N N Evotec SE 529900F9KI6OYITO9B12 Evotec SE 000000000 226972.00000000 NS 9184356.23000000 0.745464167644 Long EC CORP DE N 2 N N N Amadeus IT Group SA 9598004A3FTY3TEHHN09 Amadeus IT Group SA 000000000 359488.00000000 NS 24718477.05000000 2.006317966994 Long EC CORP ES N 2 N N N Deutsche Telekom AG 549300V9QSIG4WX4GJ96 Deutsche Telekom AG 000000000 1048410.00000000 NS 19792916.13000000 1.606526290859 Long EC CORP DE N 2 N N N Airbus SE MINO79WLOO247M1IL051 Airbus SE 000000000 235164.00000000 NS 30028839.14000000 2.437342696020 Long EC CORP FR N 2 N N N Great Portland Estates PLC 213800JMEDD2Q4N1MC42 Great Portland Estates PLC 000000000 1284682.00000000 NS 13310528.93000000 1.080372115500 Long EC CORP GB N 2 N N N AstraZeneca PLC PY6ZZQWO2IZFZC3IOL08 AstraZeneca PLC 000000000 300232.00000000 NS 34925396.44000000 2.834780243145 Long EC CORP GB N 2 N N N London Stock Exchange Group PL 213800QAUUUP6I445N30 London Stock Exchange Group PLC 000000000 222194.00000000 NS 21755781.95000000 1.765845692030 Long EC CORP GB N 2 N N N National Grid PLC 8R95QZMKZLJX5Q2XR704 National Grid PLC 000000000 1285298.00000000 NS 18807680.36000000 1.526557924561 Long EC CORP GB N 2 N N N Koninklijke DSM NV 724500SNT1MK246AHP04 Koninklijke DSM NV 000000000 106175.00000000 NS 19903614.58000000 1.615511322126 Long EC CORP NL N 2 N N N Thales SA 529900FNDVTQJOVVPZ19 Thales SA 000000000 140611.00000000 NS 12971004.61000000 1.052814036494 Long EC CORP FR N 2 N N N Ascential PLC 213800VDXQDA7KD2IQ21 Ascential PLC 000000000 2668152.00000000 NS 12745970.60000000 1.034548761634 Long EC CORP GB N 2 N N N Topdanmark AS 549300PP3ULLF0SQRK46 Topdanmark AS 000000000 232825.00000000 NS 13316034.56000000 1.080818989487 Long EC CORP DK N 2 N N N ING Groep NV 549300NYKK9MWM7GGW15 ING Groep NV 000000000 1362769.00000000 NS 20154133.07000000 1.635845088908 Long EC CORP NL N 2 N N N Julius Baer Group Ltd 5299007MF0604ZGJER92 Julius Baer Group Ltd 000000000 303810.00000000 NS 19853889.47000000 1.611475297519 Long EC CORP CH N 2 N N N Iberdrola SA 5QK37QC7NWOJ8D7WVQ45 Iberdrola SA 000000000 1801838.00000000 NS 20658191.53000000 1.676757866126 Long EC CORP ES N 2 N N N Stora Enso Oyj 7437000ZP669LKUTZ738 Stora Enso Oyj 000000000 731664.00000000 NS 14894516.66000000 1.208939220818 Long EC CORP FI N 2 N N N Banca Mediolanum SpA 7LVZJ6XRIE7VNZ4UBX81 Banca Mediolanum SpA 000000000 1302582.00000000 NS 12662282.86000000 1.027756101389 Long EC CORP IT N 2 N N N Fluidra SA 95980020140005026620 Fluidra SA 000000000 362935.00000000 NS 11556616.59000000 0.938012785143 Long EC CORP ES N 2 N N N Knorr-Bremse AG 5299001GRRO0Z25YZT52 Knorr-Bremse AG 000000000 108398.00000000 NS 10990438.41000000 0.892057953349 Long EC CORP DE N 2 N N N PRADA SpA 8156000FE0A2DC5B7852 PRADA SpA 000000000 2613400.00000000 NS 15980549.67000000 1.297088969539 Long EC CORP IT N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 117463.00000000 NS 45458108.40000000 3.689686037049 Long EC CORP CH N 2 N N N Verallia SA 5299007YZU978DE0ZY32 Verallia SA 000000000 369608.00000000 NS 11592709.36000000 0.940942317282 Long EC CORP FR N 2 N N N Zalando SE 529900YRFFGH5AXU4S86 Zalando SE 000000000 277237.00000000 NS 22003712.19000000 1.785969379022 Long EC CORP DE N 2 N N N EssilorLuxottica SA 549300M3VH1A3ER1TB49 EssilorLuxottica SA 000000000 108245.00000000 NS 20478373.94000000 1.662162660245 Long EC CORP FR N 2 N N N Lonza Group AG 549300EFW4H2TCZ71055 Lonza Group AG 000000000 30670.00000000 NS 21145182.16000000 1.716285303385 Long EC CORP CH N 2 N N N Prysmian SpA 529900X0H1IO3RS1A464 Prysmian SpA 000000000 352809.00000000 NS 11897257.47000000 0.965661491674 Long EC CORP IT N 2 N N N Swedbank AB M312WZV08Y7LYUC71685 Swedbank AB 000000000 1051026.00000000 NS 20577206.97000000 1.670184614163 Long EC CORP SE N 2 N N N Sampo Oyj 743700UF3RL386WIDA22 Sampo Oyj 000000000 375392.00000000 NS 18631769.55000000 1.512279819240 Long EC CORP FI N 2 N N N Smith & Nephew PLC 213800ZTMDN8S67S1H61 Smith & Nephew PLC 000000000 1029710.00000000 NS 17512255.50000000 1.421412523966 Long EC CORP GB N 2 N N N Siemens AG W38RGI023J3WT1HWRP32 Siemens AG 000000000 212111.00000000 NS 33677117.31000000 2.733461507315 Long EC CORP DE N 2 N N N De' Longhi SpA 8156000E09A52C4F8A38 De' Longhi SpA 000000000 330325.00000000 NS 11383502.58000000 0.923961686935 Long EC CORP IT N 2 N N N Scout24 SE 5493007EIKM2ENQS7U66 Scout24 SE 000000000 193055.00000000 NS 11533967.42000000 0.936174426064 Long EC CORP DE N 2 N N N Ashtead Group PLC 2138007UTBN8X9K1A235 Ashtead Group PLC 000000000 332136.00000000 NS 23757029.09000000 1.928280379461 Long EC CORP GB N 2 N N N Zurich Insurance Group AG 529900QVNRBND50TXP03 Zurich Insurance Group AG 000000000 62016.00000000 NS 29662772.59000000 2.407630270983 Long EC CORP CH N 2 N N N adidas AG 549300JSX0Z4CW0V5023 adidas AG 000000000 57837.00000000 NS 15871474.68000000 1.288235709213 Long EC CORP DE N 2 N N N Segro PLC 213800XC35KGM9NFC641 Segro PLC 000000000 703707.00000000 NS 12406191.24000000 1.006969981865 Long EC CORP GB N 2 N N N KION Group AG 5299005KY91C4C6U9H17 KION Group AG 000000000 54964.00000000 NS 5081600.41000000 0.412456891379 Long EC CORP DE N 2 N N N Assa Abloy AB 549300YECS8HKCIMMB67 Assa Abloy AB 000000000 597861.00000000 NS 16370696.58000000 1.328755918668 Long EC CORP SE N 2 N N N Aedas Homes SA 9598005H67MP8U20RW81 Aedas Homes SA 000000000 342689.00000000 NS 9331721.09000000 0.757425291533 Long EC CORP ES N 2 N N N T. ROWE PRICE GOVERNMENT RESERVE FUND 5493002Y0IYARJVQ5N24 T. ROWE PRICE GOVERNMENT RESERVE FUND 76105Y109 12069481.69000000 NS USD 12069481.69000000 0.979640368537 Long STIV RF US N 1 N N Davide Campari-Milano NV 213800ED5AN2J56N6Z02 Davide Campari-Milano NV 000000000 1269405.00000000 NS 15937754.92000000 1.293615459596 Long EC CORP IT N 2 N N N Husqvarna AB 549300GYQIIJ3UXB7655 Husqvarna AB 000000000 929334.00000000 NS 12921428.18000000 1.048790079757 Long EC CORP SE N 2 N N N Teleperformance 9695004GI61FHFFNRG61 Teleperformance 000000000 45772.00000000 NS 17237235.59000000 1.399090057028 Long EC CORP FR N 2 N N N Kering SA 549300VGEJKB7SVUZR78 Kering SA 000000000 26661.00000000 NS 19909503.96000000 1.615989343845 Long EC CORP FR N 2 N N N Howden Joinery Group PLC 213800KC1LJOJTY3JP45 Howden Joinery Group PLC 000000000 1198328.00000000 NS 13220484.30000000 1.073063487277 Long EC CORP GB N 2 N N N Ferrari NV 549300RIVY5EX8RCON76 Ferrari NV 000000000 76518.00000000 NS 17635305.71000000 1.431400107209 Long EC CORP IT N 2 N N N Epiroc AB 5493004Q73OEYW1SPE91 Epiroc AB 000000000 834393.00000000 NS 17805222.81000000 1.445191722685 Long EC CORP SE N 2 N N N Infineon Technologies AG TSI2PJM6EPETEQ4X1U25 Infineon Technologies AG 000000000 421659.00000000 NS 17510551.88000000 1.421274246700 Long EC CORP DE N 2 N N N Jeronimo Martins SGPS SA 259400A8SZP10GB5IB19 Jeronimo Martins SGPS SA 000000000 861118.00000000 NS 20693564.87000000 1.679629004483 Long EC CORP PT N 2 N N N Mondi PLC 213800LOZA69QFDC9N34 Mondi PLC 000000000 563354.00000000 NS 14094662.15000000 1.144017645304 Long EC CORP GB N 2 N N N 2022-03-24 T. ROWE PRICE INTERNATIONAL FUNDS, INC. Alan S. Dupski Alan S. Dupski Treasurer & Vice President XXXX NPORT-EX 2 7040TRP013122.htm
T.
ROWE
PRICE
European
Stock
Fund
January
31,
2022
(Unaudited)
1
Portfolio
of
Investments
Shares
$
Value
(
Cost
and
value
in
$000s)
AUSTRIA
2.1%
Common
Stocks
2.1%
BAWAG
Group 
290,308‌
17,423‌
Mayr
Melnhof
Karton 
44,633‌
8,683‌
Total
Austria
(Cost
$21,232
)
26,106‌
DENMARK
2.4%
Common
Stocks
2.4%
ROCKWOOL
International,
B
Shares 
43,088‌
16,503‌
Topdanmark 
232,825‌
13,316‌
Total
Denmark
(Cost
$24,982
)
29,819‌
FINLAND
3.8%
Common
Stocks
3.8%
Sampo,
Class
375,392‌
18,632‌
Stora
Enso,
Class
731,664‌
14,895‌
Valmet 
348,781‌
13,321‌
Total
Finland
(Cost
$33,378
)
46,848‌
FRANCE
12.7%
Common
Stocks
12.7%
Airbus (1)
235,164‌
30,029‌
Edenred 
405,940‌
17,436‌
EssilorLuxottica 
108,245‌
20,478‌
Kering 
26,661‌
19,910‌
Sanofi 
253,499‌
26,506‌
Teleperformance 
45,772‌
17,237‌
Thales 
140,611‌
12,971‌
Verallia 
369,608‌
11,593‌
Total
France
(Cost
$143,315
)
156,160‌
GERMANY
12.9%
Common
Stocks
12.9%
adidas 
57,837‌
15,871‌
Deutsche
Telekom 
1,048,410‌
19,793‌
Evotec (1)
226,972‌
9,184‌
Infineon
Technologies 
421,659‌
17,511‌
T.
ROWE
PRICE
European
Stock
Fund
2
Shares
$
Value
(Cost
and
value
in
$000s)
KION
Group 
18,774‌
1,736‌
Knorr-Bremse 
108,398‌
10,990‌
Scout24 
193,055‌
11,534‌
Siemens 
212,111‌
33,677‌
Symrise 
140,476‌
16,787‌
Zalando (1)
277,237‌
22,004‌
Total
Germany
(Cost
$133,599
)
159,087‌
ITALY
8.0%
Common
Stocks
8.0%
Banca
Mediolanum 
1,302,582‌
12,662‌
Davide
Campari-Milano 
1,269,405‌
15,938‌
De'
Longhi 
330,325‌
11,383‌
Ferrari 
76,518‌
17,635‌
FinecoBank
Banca
Fineco 
753,360‌
12,666‌
PRADA 
2,613,400‌
15,981‌
Prysmian 
352,809‌
11,897‌
Total
Italy
(Cost
$77,507
)
98,162‌
NETHERLANDS
8.9%
Common
Stocks
8.9%
Akzo
Nobel 
198,735‌
20,571‌
ASML
Holding 
72,613‌
49,180‌
ING
Groep 
1,362,769‌
20,154‌
Koninklijke
DSM 
106,175‌
19,904‌
Total
Netherlands
(Cost
$66,467
)
109,809‌
PORTUGAL
1.7%
Common
Stocks
1.7%
Jeronimo
Martins 
861,118‌
20,694‌
Total
Portugal
(Cost
$14,696
)
20,694‌
SPAIN
7.0%
Common
Stocks
7.0%
Aedas
Homes 
342,689‌
9,332‌
Amadeus
IT
Group,
Class
A (1)
359,488‌
24,718‌
Cellnex
Telecom 
444,016‌
20,134‌
Fluidra 
362,935‌
11,557‌
T.
ROWE
PRICE
European
Stock
Fund
3
Shares
$
Value
(Cost
and
value
in
$000s)
Iberdrola 
1,801,838‌
20,658‌
Total
Spain
(Cost
$73,936
)
86,399‌
SWEDEN
5.5%
Common
Stocks
5.5%
Assa
Abloy,
Class
614,850‌
16,836‌
Epiroc,
Class
834,393‌
17,805‌
Husqvarna,
B
Shares 
929,334‌
12,922‌
Swedbank,
Class
1,051,026‌
20,577‌
Total
Sweden
(Cost
$46,161
)
68,140‌
SWITZERLAND
13.3%
Common
Stocks
13.3%
Alcon 
258,922‌
19,965‌
Barry
Callebaut 
6,699‌
15,378‌
Julius
Baer
Group 
303,810‌
19,854‌
Lonza
Group 
30,670‌
21,145‌
Partners
Group
Holding 
8,616‌
12,013‌
Roche
Holding 
117,463‌
45,458‌
Zurich
Insurance
Group 
62,016‌
29,663‌
Total
Switzerland
(Cost
$119,270
)
163,476‌
UNITED
KINGDOM
20.6%
Common
Stocks
20.6%
Ascential (1)
2,668,152‌
12,746‌
Ashtead
Group 
345,459‌
24,710‌
AstraZeneca 
300,232‌
34,925‌
Bridgepoint
Group (1)
1,259,146‌
6,554‌
Dechra
Pharmaceuticals 
222,975‌
12,524‌
Experian 
395,378‌
16,514‌
Great
Portland
Estates 
1,284,682‌
13,311‌
Greggs 
308,663‌
11,194‌
Howden
Joinery
Group 
1,198,328‌
13,220‌
InterContinental
Hotels
Group (1)
278,056‌
18,372‌
London
Stock
Exchange
Group 
222,194‌
21,756‌
Mondi 
563,354‌
14,095‌
National
Grid 
1,285,298‌
18,808‌
Segro 
703,707‌
12,406‌
Smith
&
Nephew 
1,029,710‌
17,512‌
Trainline (1)
1,616,448‌
4,894‌
Total
United
Kingdom
(Cost
$214,526
)
253,541‌
T.
ROWE
PRICE
European
Stock
Fund
4
Shares
$
Value
(Cost
and
value
in
$000s)
SHORT-TERM
INVESTMENTS
1.0%
Money
Market
Funds
1.0%
T.
Rowe
Price
Government
Reserve
Fund,
0.09% (2)(3)
12,069,830‌
12,070‌
Total
Short-Term
Investments
(Cost
$12,070)
12,070‌
Total
Investments
in
Securities
99.9%
(Cost
$981,139)
$
1,230,311‌
Other
Assets
Less
Liabilities
0.1%
1,596
Net
Assets
100.0%
$
1,231,907‌
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Non-income
producing
(2)
Seven-day
yield
(3)
Affiliated
Companies
T.
ROWE
PRICE
European
Stock
Fund
5
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
January
31,
2022.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
0.09%
$
—‌
#
$
—‌
$
1‌
+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/21
Purchase
Cost
Sales
Cost
Value
01/31/22
T.
Rowe
Price
Government
Reserve
Fund,
0.09%
$
22,347‌
¤
¤
$
12,070‌
^
#
Capital
gain
distributions
from
mutual
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$1
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$12,070.
T.
ROWE
PRICE
European
Stock
Fund
Unaudited
Notes
to
Portfolio
of
Investments
6
T.
Rowe
Price
European
Stock
Fund (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus. 
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The
T.
Rowe
Price
Valuation
Committee
(the
Valuation
Committee)
is
an
internal
committee
that
has
been
delegated
certain
responsibilities
by
the
fund’s
Board
of
Directors
(the
Board)
to
ensure
that
financial
instruments
are
appropriately
priced
at
fair
value
in
accordance
with
GAAP
and
the
1940
Act.
Subject
to
oversight
by
the
Board,
the
Valuation
Committee
develops
and
oversees
pricing-related
policies
and
procedures
and
approves
all
fair
value
determinations.
Specifically,
the
Valuation
Committee
establishes
policies
and
procedures
used
in
valuing
financial
instruments,
including
those
which
cannot
be
valued
in
accordance
with
normal
procedures
or
using
pricing
vendors;
determines
pricing
techniques,
sources,
and
persons
eligible
to
effect
fair
value
pricing
actions;
evaluates
the
services
and
performance
of
the
pricing
vendors;
oversees
the
pricing
process
to
ensure
policies
and
procedures
are
being
followed;
and
provides
guidance
on
internal
controls
and
valuation-related
matters.
The
Valuation
Committee
provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
T.
ROWE
PRICE
European
Stock
Fund
7
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the fund’s
own
assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the
fund
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
its
portfolio
securities.
Each
business
day,
the
fund
uses
information
from
outside
pricing
services
to
evaluate
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The
fund
uses
outside
pricing
services
T.
ROWE
PRICE
European
Stock
Fund
8
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The
fund
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations
or
market-based
valuations
are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Committee,
in
accordance
with
fair
valuation
policies
and
procedures.
The
objective
of
any
fair
value
pricing
determination
is
to
arrive
at
a
price
that
could
reasonably
be
expected
from
a
current
sale.
Financial
instruments
fair
valued
by
the
Valuation
Committee
are
primarily
private
placements,
restricted
securities,
warrants,
rights,
and
other
securities
that
are
not
publicly
traded.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Committee
typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Committee
may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis
and
updated
as
information
becomes
available,
including
actual
purchase
and
sale
transactions
of
the
investment.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions,
and
fair
value
prices
determined
by
the
Valuation
Committee
could
differ
from
those
of
other
market
participants.
T.
ROWE
PRICE
European
Stock
Fund
9
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
January
31,
2022
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
SUBSEQUENT
EVENT 
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict.
Economic
sanctions
have
since
been
imposed
on
Russia
and
certain
of
its
citizens,
including
the
exclusion
of
Russia
from
the
SWIFT
global
payments
network.
As
a
result,
Russia’s
central
bank
closed
the
country’s
stock
market
on
February
28,
2022,
and
Russian-related
stocks
and
debt
and
the
Russian
ruble
have
since
suffered
significant
declines
in
value.
In
addition,
this
armed
conflict
and
the
related
sanctions
may
cause
significant
disruptions
to
global
business
activity
and
volatility
in
global
financial
markets.
The
duration
of
the
conflict
and
related
economic
sanctions
and
their
effects
on
the
financial
markets
cannot
be
determined
with
certainty.
The
fund’s
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
such
events.
Management
is
actively
monitoring
these
events.
F79-054Q1
01/22 
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
$
1,218,241
$
$
1,218,241
Short-Term
Investments
12,070
12,070
Total
$
12,070
$
1,218,241
$
$
1,230,311